Comparison
Why is Mirum Pharmaceuticals, Inc. ?
- OPERATING CASH FLOW(Y) Lowest at USD -170.97 MM
- ROCE(HY) Lowest at -335.82%
- DEBTORS TURNOVER RATIO(HY) Lowest at 4.98 times
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 110.89%, its profits have risen by 73.4%
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Mirum Pharmaceuticals, Inc. for you?
High Risk, High Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at USD 159.88 MM
Fallen by -3.33% (YoY
Highest at USD 769.59 MM
Lowest at -25.77 %
Highest at 4.44 times
Lowest at USD -170.97 MM
Lowest at -335.82%
Lowest at 4.98 times
Lowest at USD -56.29 MM
Lowest at -35.21 %
Lowest at USD -64.38 MM
Lowest at USD -64.85 MM
Lowest at USD -13.43
Here's what is working for Mirum Pharmaceuticals, Inc.
Net Sales (USD MM)
Net Sales (USD MM)
Cash and Cash Equivalents
Debt-Equity Ratio
Inventory Turnover Ratio
Raw Material Cost as a percentage of Sales
Depreciation (USD MM)
Here's what is not working for Mirum Pharmaceuticals, Inc.
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
Operating Cash Flows (USD MM)
Operating Profit (USD MM)
Operating Profit to Sales
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
EPS (USD)
Debtors Turnover Ratio






